STAT+: Pharmalittle: AbbVie buys Immunogen, maker of targeted cancer drugs; Novo sues two more compounders
STAT
NOVEMBER 30, 2023
Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. Testing of compounded drugs from these pharmacies revealed unknown impurities up to 33%, the company claims.
Let's personalize your content